Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Wound Healing in Pediatric Burns
NCT01666665Phase 3Terminated
- Sponsor
- The University of Texas Medical Branch at Galveston
- Start
- Nov 2012
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of liquid metformin (Aspargo Labs) in burn injury (2 arms), sponsored by The University of Texas Medical Branch at Galveston. Primary endpoint: Insulin resistance at 2 years. Started Nov 2012; status: terminated.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT01666665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01666665.